A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01237236
Recruitment Status : Completed
First Posted : November 9, 2010
Last Update Posted : August 23, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 9, 2017
  Actual Study Completion Date : March 9, 2017